Your Messages Inbox
Your Article Summary
See Latest ArticlesBiomarkers: Promises and Challenges
PharmExec, 10/15/09
Molecular biomarkers are emerging as key indices for discovery, development, approval, safety, value assessment and individualized medicine. They can and should be employed in all stages of drug development, from pre–clinical through post–marketing. Biomarkers, which are not new to medicine and drug development, are often classified as traditional, preventive, diagnostic, prognostic and predictive.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Important progress in treatment of early and late stage breast cancer with Herceptin, Avastin and T-DM1
Roche, 12/10/09
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
Sanofi-aventis, 12/10/09
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09
Article Search
Sponsor